Lv21
110 积分 2022-06-24 加入
Asymmetric synthesis of sulfoximines, sulfonimidoyl fluorides and sulfonimidamides enabled by an enantiopure bifunctional S(VI) reagent
2小时前
已完结
Risankizumab versus ustekinumab for Crohn’s disease: a phase IIIb study
2个月前
已关闭
The pipeline and market for psoriasis drugs
2个月前
已完结
The metabolic nature of inflammatory bowel diseases
3个月前
已完结
TYK2: an emerging therapeutic target in rheumatic disease
5个月前
已完结
Safety and Preliminary Efficacy of DFV890 in Adult Patients with Myeloid Diseases: A Phase 1b Study
7个月前
已关闭
Discovery of the TLR7/8 Antagonist MHV370 for Treatment of Systemic Autoimmune Diseases
9个月前
已完结
Complement therapeutics are coming of age in rheumatology
1年前
已完结
Chapter Twenty-Three - Identification and characterization of TYK2 pseudokinase domain stabilizers that allosterically inhibit TYK2 signaling
1年前
已完结
Synthesis and structure-activity optimization of 7-azaindoles containing aza-β-amino acids targeting the influenza PB2 subunit
1年前
已完结
Inhibiting metallo-β-lactamases
2个月前
已驳回
Inhibiting metallo-β-lactamases
2个月前
已驳回
皖公网安备34019202002308
